The budding demand for quick diagnosis of life-threatening diseases has increased product approvals for saliva collecting and diagnostic devices. As per MRFR, The Saliva Collection & Diagnostics Market Size was valued at USD 2.2 billion in 2022 and is projected to grow from USD 2.4 Billion in 2023 to USD 5.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.17% during the forecast period (2023 - 2030).
The requirement for saliva collecting equipment in the market is skyrocketing, owing to an increase in the number of disorders requiring saliva samples' testing. The saliva collection devices market, on the other hand, is severely hampered by the large debts of setting up the equipment required to conduct quality and ethical saliva collection. The global Saliva Collection and Diagnostics Market is primarily driven by widespread improvements in healthcare and medicine, particularly in the testing and development of new medical procedures, medications, and experiments.
Segmental Analysis
The saliva collection and diagnostic market segmentation is conducted based on the site of collection, region, application, and end user.
- based on the collection site been segmented into submandibular/sublingual gland collection, minor salivary glands collection, and parotid gland collection.
- The end user segment has been segregated into hospitals, dental clinics, investigation laboratories, and diagnostic centres.
- Segmented By Application: Disease diagnosis, pharmaceutical, and biotechnology firms, and forensics have been.
- By region, the saliva collection and diagnostic market are segmented into Europe, Asia-Pacific, the Americas, and the Middle East & Africa.
Key Players:
The central Saliva Collection and Diagnostics Market Players are OraSure Technologies (US), SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), Neogen Corporation. (US)., and Abbott Laboratories (US).
Detailed Regional Analysis
The regional assessment of the saliva collection and diagnostic market is segmented into Europe, Asia-Pacific, the Americas, and the Middle East & Africa. During the forecast era, the Americas led the market and is set to continue to do so during the evaluation period. This is due to developments in illness testing technology and an increase in the prevalence of chronic diseases. Due to various favorable government initiatives, a wide target population base, and an increased cancer rate, Europe would trail the Americas in terms of value during the predicted period. Escalating per capita health spending, the development of the healthcare sector in China, India, and Australia, burgeoning demand for saliva collection and diagnostic tools for respiratory procedures, and an aging population suffering from various diseases, Asia-Pacific is reported to witness the highest growth potential during the forecast period.
Competitive Analysis
After the decline seen in the aftermath of the pandemic, the government bodies of various nations are believed to play an important role in the worldwide market's resuscitation. The minimization of supply chain bottlenecks is the main objective that market challengers are intended to address aggressively in the predicted year. During the forecast period, the market is anticipated to offer new and profitable expansion options. The battle for the majority share is predicted to change the market landscape in the forecast period fundamentally. The market is more inclined to conduct business transactions online than in physical locations. End-users in the business are predicted to exhibit a wide range of preferences in the coming years. Companies now have a new mission surrounding the customer journey and the rapid acceleration of digitalization due to the global pandemic. However, the upheaval produced by the COVID crisis has not only created a whole new dimension of risk. Still, it has also prompted enterprises to reassess risks as they navigate cautiously through an uncertain economic climate.
Industry Updates:
- July 2021 Psomagen, Inc., a CLIA-certified genetic analysis service provider, expands its SARS-CoV-2 diagnostic services to meet the public's changing COVID-19 testing demands. The company now offers direct-to-consumer saliva collection kits for diagnosing COVID-19 for individuals 18 and older, in addition to its GutBiome and Gene Trait testing.
Related Reports:
https://www.linkedin.com/pulse/urinary-tract-infection-market-2022-trend-analysis-financial-gupta-1c
https://frustratedgamers.com/read-blog/134461
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
